CWM
ALLO icon

CIBC World Markets’s Allogene Therapeutics ALLO Stock Holding History

CIBC World Markets’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$13.9K Buy
+10,177
New +$13.4K ﹤0.01% 1229
2025
Q2 		$21.1K Sell
18,682
-9,801
-34% -$13K ﹤0.01% 1528
2025
Q1 		$41.6K Buy
28,483
+16,470
+137% +$31.1K ﹤0.01% 1735
2024
Q4 		$25.6K Buy
+12,013
New +$29.6K ﹤0.01% 1300

Other funds holding ALLO

P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

CIBC World Markets's ALLO Position: Q4 2025 in Review

CIBC World Markets opened a new position in Allogene Therapeutics (ALLO) in Q4 2025: 10,177 shares worth $13.9K. The stake represents ﹤0.01% of the portfolio and ranks #1229 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in ALLO as recently as Q2 2025.

CIBC World Markets first reported a position in ALLO in Q4 2024 and has held it in 4 quarters since. The position peaked at $41.6K in Q1 2025. 172 funds tracked by Wall St. Rank hold ALLO as of Q4 2025.

  • CIBC World Markets held 10,177 shares of Allogene Therapeutics worth $13.9K as of Q4 2025.
  • Allogene Therapeutics was a new CIBC World Markets position in Q4 2025.
  • Allogene Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1229 holding.
  • CIBC World Markets first reported a position in Allogene Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Allogene Therapeutics position peaked at $41.6K in Q1 2025.
  • 172 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.